Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib

Author： Chahardouli Bahram   Zaker Farhad   Mousavi Seied Asadollah   Saffari Zeinab   Nadali Fatemeh   Ostadali Mohammadreza   Ghadimi Habibeh   Alimoghaddam Kamran   Ghavamzade Ardeshir   Rostami Shahrbano  

Publisher： Maney Publishing

ISSN： 1024-5332

Source： Hematology, Vol.18, Iss.6, 2013-11, pp. : 327-332

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Not all imatinib resistance in CML are BCR-ABL kinase domain mutations

By Wei Yuan   Hardling Mats   Olsson Bob   Hezaveh Rahil   Ricksten Anne   Stockelberg Dick   Wadenvik Hans  

Annals of Hematology, Vol. 85, Iss. 12, 2006-12 ,pp. : 841-847

Springer Publishing Company

Access to resources Recommend Favorite

AHI1 gene expression levels and BCR-ABL1 T315I mutations in chronic myeloid leukemia patients

By Balci Tugce Bulakbasi   Sahin Feride Iffet   Karakus Sema   Ozdogu Hakan  

Hematology, Vol. 16, Iss. 6, 2011-11 ,pp. : 357-360

Maney Publishing

Access to resources Recommend Favorite

Targeting the Kinase Activity of the BCR-ABL Fusion Protein in Patients with Chronic Myeloid Leukemia

By  

Current Molecular Medicine, Vol. 5, Iss. 7, 2005-11 ,pp. : 615-623

Bentham Science Publishers

Access to resources Recommend Favorite

Unusual location of BCR-ABL1 fusion sequences in a chronic myeloid leukemia patient

By Zámečníkova Adriana   Al Bahar Soad   Pandita Ramesh  

Hematology, Vol. 17, Iss. 6, 2012-11 ,pp. : 321-324

Maney Publishing

Access to resources Recommend Favorite

Reconsideration of BCR‐ABL protein flow cytometric immunobead assay: how potent to diagnose and monitor chronic myeloid leukemia?

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : 723-728

John Wiley & Sons Inc

Access to resources Recommend Favorite